Dr Reddy's launches OTC acid reflux drug in US market
New Delhi: Drug major Dr Reddy's Laboratories (DRL) announced the launch of over-the-counter Esomeprazole magnesium delayed-release capsules USP, 20 mg, used to treat acid reflux, in the US market.
Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg is an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24 hour capsules.
"This launch continues to demonstrate our deep R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market," Dr Reddy's Laboratories Vice President and Head, US OTC and Speciality Rx businesses, Milan Kalawadia said.
Quoting IRI data, the company said the combined market of Nexium 24 hour capsules and private label OTC Esomeprazole Magnesium products had US sales of approximately USD 311 million for the most recent 12 months ending in May 2018.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd